Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
Nature Medicine2006Vol. 13(1), pp. 35–37
Citations Over TimeTop 1% of 2006 papers
Christel Rousseaux, Xavier Thuru, Agathe Gelot, Nicolas Barnich, Christel Neut, Laurent Dubuquoy, Caroline Dubuquoy, Emilie Mérour, Karen Geboes, Mathias Chamaillard, Arthur C. Ouwehand, Greg Leyer, Didier Carcano, Jean–Frédéric Colombel, Denis Ardid, Pierre Desreumaux
Related Papers
- → Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes(2002)101 cited
- → Cannabinoid–improgan cross-tolerance: Improgan is a cannabinomimetic analgesic lacking affinity at the cannabinoid CB1 receptor(2006)9 cited
- → Pharmacological characterization of the cannabinoid CB1 receptor PET ligand ortholog, [3H]MePPEP(2010)6 cited
- → Cannabinoid Ligand-Receptor Signaling During Early Pregnancy in the Mouse(1999)3 cited
- → Identification of existing drugs effective for visceral pain relevant to irritable bowel syndrome through phenotypic screening in rats(2018)